(M)‐ and (P)‐8‐[(1S,2R)‐2‐hydroxy‐1‐methyl‐2‐phenylethyl]‐8‐methyl‐8,9‐dihydro‐7H‐dinaphth[2,1‐c:1′,2′‐e]azepinium bromide solvates

The title compounds are diastereoisomers with antipodean axial chirality. The M isomer crystallizes as a (1/3) acetone solvate, C₃₂H₃₀NO⁺·Br^?·3C₃H₆O, while the P isomer crystallizes as a (1/1) di­chloro­methane solvate, C₃₂H₃₀NO⁺·Br^?·CH₂Cl₂. In each structure, O—H?Br hydrogen bonds link the cations and anions to give ion pairs. The seven‐membered azepinium ring adopts the usual twisted‐boat conformation and its ring strain causes a slight curvature of the plane of each naphthyl ring.     

Comparison of the methyl ester of l‐tyrosine hydrochloride and its methanol monosolvate

Solvent‐free (2S)‐methyl 2‐ammonio‐3‐(4‐hydroxy­phenyl)­propionate chloride, C₁₀H₁₄NO₃⁺·Cl⁻, (I), and its methanol solvate, C₁₀H₁₄NO₃⁺·Cl⁻·CH₃OH, (II), are obtained from different solvents: crystallization from ethanol or propan‐2‐ol gives the same solvent‐free crystals of (I) in both cases, while crystals of (II) were obtained by crystallization from methanol. The structure of (I) is characterized by the presence of two‐dimensional layers linked together by N—H⋯Cl and O—H⋯Cl hydrogen bonds and also by C—H⋯O contacts. Incorporation of the methanol solvent mol­ecule in (II) introduces additional O—H⋯O hydrogen bonds linking the two‐dimensional layers, resulting in the formation of a three‐dimensional network.     

Solvent‐mediated pseudo‐quadruple hydrogen‐bond motifs in three lamotrigine–carboxylic acid complexes

Lamotrigine, an antiepileptic drug, has been complexed with three aromatic carboxylic acids. All three compounds crystallize with the inclusion of N,N‐dimethylformamide (DMF) solvent, viz. lamotriginium [3,5‐diamino‐6‐(2,3‐dichlorophenyl)‐1,2,4‐triazin‐2‐ium] 4‐iodobenzoate N,N‐dimethylformamide monosolvate, C₉H₈Cl₂N₅⁺·C₇H₄IO₂⁻·C₃H₇NO, (I), lamotriginium 4‐methylbenzoate N,N‐dimethylformamide monosolvate, C₉H₇Cl₂N₅⁺·C₈H₈O₂⁻·C₃H₇NO, (II), and lamotriginium 3,5‐dinitro‐2‐hydroxybenzoate N,N‐dimethylformamide monosolvate, C₉H₈Cl₂N₅⁺·C₇H₃N₂O₇⁻·C₃H₇NO, (III). In all three structures, proton transfer takes place from the acid to the lamotrigine molecule. However, in (I) and (II), the acidic H atom is disordered over two sites and there is only partial transfer of the H atom from O to N. In (III), the corresponding H atom is ordered and complete proton transfer has occurred. Lamotrigine–lamotrigine, lamotrigine–acid and lamotrigine–solvent interactions are observed in all three structures and they thereby exhibit isostructurality. The DMF solvent extends the lamotrigine–lamotrigine dimers into a pseudo‐quadruple hydrogen‐bonding motif.     

Preparation and X‐ray analysis of potassium (2,3‐dichlorophenyl)glucosinolate

There has been much interest in obtaining crystals for crystallographic analysis of biologically active glucosinolates. Crystals of potassium (2,3‐dichlorophenyl)glucosinolate were obtained as a dual solvate, containing one methanol and one ethanol molecule of crystallization, K⁺·C₁₃H₁₄Cl₂NO₉S₂⁻·CH₃OH·C₂H₅OH. The three‐dimensional polymeric network consists of chains containing the potassium ions coordinated and bridged by sugar O atoms, which run parallel to the a axis and are further crosslinked through the sugar molecules. The channels of this network are occupied by the dichlorophenyl substituents and the ethanol and methanol solvent molecules. The structure of the S‐(2,3,4,6‐tetra‐O‐acetyl‐β‐D‐glucopyranosyl)‐2,3‐dichlorophenylacetothiohydroxymate, C₂₁H₂₃Cl₂NO₁₀S, precursor has also been determined and the β‐configuration and Z isomer of the thiohydroximate substituent is confirmed.     

Pseudopolymorphs of chelidamic acid and its dimethyl ester

Different tautomeric and zwitterionic forms of chelidamic acid (4‐hydroxypyridine‐2,6‐dicarboxylic acid) are present in the crystal structures of chelidamic acid methanol monosolvate, C₇H₅NO₅·CH₄O, (Ia), dimethylammonium chelidamate (dimethylammonium 6‐carboxy‐4‐hydroxypyridine‐2‐carboxylate), C₂H₈N⁺·C₇H₄NO₅⁻, (Ib), and chelidamic acid dimethyl sulfoxide monosolvate, C₇H₅NO₅·C₂H₆OS, (Ic). While the zwitterionic pyridinium carboxylate in (Ia) can be explained from the pK_a values, a (partially) deprotonated hydroxy group in the presence of a neutral carboxy group, as observed in (Ib) and (Ic), is unexpected. In (Ib), there are two formula units in the asymmetric unit with the chelidamic acid entities connected by a symmetric O—H...O hydrogen bond. Also, crystals of chelidamic acid dimethyl ester (dimethyl 4‐hydroxypyridine‐2,6‐dicarboxylate) were obtained as a monohydrate, C₉H₉NO₅·H₂O, (IIa), and as a solvent‐free modification, in which both ester molecules adopt the hydroxypyridine form. In (IIa), the solvent water molecule stabilizes the synperiplanar conformation of both carbonyl O atoms with respect to the pyridine N atom by two O—H...O hydrogen bonds, whereas an antiperiplanar arrangement is observed in the water‐free structure. A database study and ab initio energy calculations help to compare the stabilities of the various ester conformations.     

One‐dimensional hydrogen‐bonded structures in the 1:1 proton‐transfer compounds of 4,5‐dichlorophthalic acid with 8‐hydroxyquinoline, 8‐aminoquinoline and quinoline‐2‐carboxylic acid (quinaldic acid)

The structures of the 1:1 proton‐transfer compounds of 4,5‐dichlorophthalic acid with 8‐hydroxyquinoline, 8‐aminoquinoline and quinoline‐2‐carboxylic acid (quinaldic acid), namely anhydrous 8‐hydroxyquinolinium 2‐carboxy‐4,5‐dichlorobenzoate, C₉H₈NO⁺·C₈H₃Cl₂O₄⁻, (I), 8‐aminoquinolinium 2‐carboxy‐4,5‐dichlorobenzoate, C₉H₉N₂⁺·C₈H₃Cl₂O₄⁻, (II), and the adduct hydrate 2‐carboxyquinolinium 2‐carboxy‐4,5‐dichlorobenzoate quinolinium‐2‐carboxylate monohydrate, C₁₀H₈NO₂⁺·C₈H₃Cl₂O₄⁻·C₁₀H₇NO₂·H₂O, (III), have been determined at 130 K. Compounds (I) and (II) are isomorphous and all three compounds have one‐dimensional hydrogen‐bonded chain structures, formed in (I) through O—H...O_carboxyl extensions and in (II) through N⁺—H...O_carboxyl extensions of cation–anion pairs. In (III), a hydrogen‐bonded cyclic R₂²(10) pseudo‐dimer unit comprising a protonated quinaldic acid cation and a zwitterionic quinaldic acid adduct molecule is found and is propagated through carboxylic acid O—H...O_carboxyl and water O—H...O_carboxyl interactions. In both (I) and (II), there are also cation–anion aromatic ring π–π associations. This work further illustrates the utility of both hydrogen phthalate anions and interactive‐group‐substituted quinoline cations in the formation of low‐dimensional hydrogen‐bonded structures.     

Neutral 4‐phenyl‐1‐[phenyl(pyridin‐2‐yl)methylidene]semicarbazide and its salt forms with inorganic anions

Semicarbazones can exist in two tautomeric forms. In the solid state, they are found in the keto form. This work presents the synthesis, structures and spectroscopic characterization (IR and NMR spectroscopy) of four such compounds, namely the neutral molecule 4‐phenyl‐1‐[phenyl(pyridin‐2‐yl)methylidene]semicarbazide, C₁₉H₁₆N₄O, (I), abbreviated as HBzPyS, and three different hydrated salts, namely the chloride dihydrate, C₁₉H₁₇N₄O⁺·Cl^?·2H₂O, (II), the nitrate dihydrate, C₁₉H₁₇N₄O⁺·NO₃^?·2H₂O, (III), and the thiocyanate 2.5‐hydrate, C₁₉H₁₇N₄O⁺·SCN^?·2.5H₂O, (IV), of 2‐[phenyl({[(phenylcarbamoyl)amino]imino})methyl]pyridinium, abbreviated as [H₂BzPyS]⁺·X^?·nH₂O, with X = Cl^? and n = 2 for (II), X = NO₃^? and n = 2 for (III), and X = SCN^? and n = 2.5 for (IV), showing the influence of the anionic form in the intermolecular interactions. Water molecules and counter‐ions (chloride or nitrate) are involved in the formation of a two‐dimensional arrangement by the establishment of hydrogen bonds with the N—H groups of the cation, stabilizing the E isomers in the solid state. The neutral HBzPyS molecule crystallized as the E isomer due to the existence of weak π–π interactions between pairs of molecules. The calculated IR spectrum of the hydrated [H₂BzPyS]⁺ cation is in good agreement with the experimental results.     

Differences and similarities among hypoxanthinium nitrate hydrate structures

Crystals of hypoxanthinium (6‐oxo‐1H,7H‐purin‐9‐ium) nitrate hydrates were investigated by means of X‐ray diffraction at different temperatures. The data for hypoxanthinium nitrate monohydrate (C₅H₅N₄O⁺·NO₃^?·H₂O, Hx1 ) were collected at 20, 105 and 285 K. The room‐temperature phase was reported previously [Schmalle et al. (1990). Acta Cryst. C 46 , 340–342] and the low‐temperature phase has not been investigated yet. The structure underwent a phase transition, which resulted in a change of space group from Pmnb to P2₁/n at lower temperature and subsequently in nonmerohedral twinning. The structure of hypoxanthinium dinitrate trihydrate (H₃O⁺·C₅H₅N₄O⁺·2NO₃^?·2H₂O, Hx2 ) was determined at 20 and 100 K, and also has not been reported previously. The Hx2 structure consists of two types of layers: the `hypoxanthinium nitrate monohydrate' layers (HX) observed in Hx1 and layers of Zundel complex H₃O⁺·H₂O interacting with nitrate anions (OX). The crystal can be considered as a solid solution of two salts, i.e. hypoxanthinium nitrate monohydrate, C₅H₅N₄O⁺·NO₃^?·H₂O, and oxonium nitrate monohydrate, H₃O⁺(H₂O)·NO₃^?.     

Role of halogen–halogen contacts in the crystal structures of three new solvates of the drug oxyclozanide

Halogen–halogen contacts are electrostatic in nature and exhibit directionality similar to hydrogen bonds. Oxyclozanide [systematic name: 2,3,5‐trichloro‐N‐(3,5‐dichloro‐2‐hydroxyphenyl)‐6‐hydroxybenzamide] is a drug used for the treatment of fascioliasis in domestic animals. The molecule carries five chlorine substituents and represents an ideal candidate for the study of halogen bonds in the crystal. Three new crystalline solvates of oxyclozanide, namely, oxyclozanide benzene hemisolvate, C₁₃H₆Cl₅NO₃·0.5C₆H₆, (I), oxyclozanide xylene hemisolvate, C₁₃H₆Cl₅NO₃·0.5C₈H₁₀, (II), and oxyclozanide toluene hemisolvate, C₁₃H₆Cl₅NO₃·0.5C₇H₈, (III), were structurally characterized. In this context, the crystal structure of oxyclozanide chlorobenzene hemisolvate, C₁₃H₆Cl₅NO₃·0.5C₆H₅Cl, (IV), was redetermined based on intensity data collected at 100 K. In all four solvates, the cocrystallized solvent molecules are located on crystallographic inversion centres. Solvates (I)–(IV) exhibit similar one‐dimensional hydrogen‐bonded chains generated by O—H…O, O—H…Cl and Cl…Cl interactions. The extension of these one‐dimensional chains into two‐dimensional layers is promoted by Cl…Cl and C—H…π contacts. Solvates (III) and (IV) are isostructural and differ from (I) and (II) with respect to subtle details concerning the intermolecular contacts.     

Three copper(II) complexes constructed from 4-(2-pyridyl)-<Emphasis Type="Italic">1H</Emphasis>-1,2,3-triazole ligands: syntheses,structures, optical,and electrochemical properties

Three Cu(II) complexes constructed from 4-(2-pyridyl)-1H-1,2,3-triazole (L), namely, [CuL₂Cl₂]·H₂O, [CuL₂(CH₃OH)(NO₃)]NO₃ and [CuL₂(H₂O)]SO₄, have been synthesized and characterized. X-ray crystal structure analyses revealed that [CuL₂Cl₂]·H₂O and [CuL₂(CH₃OH)(NO₃)]NO₃ have octahedral geometries, whilst [CuL₂(H₂O)]SO₄ adopts a square-pyramidal coordination geometry. In all three complexes, the Cu(II) atoms are chelated by two L ligands in the basal plane, whilst the apical positions are occupied by Cl^?, NO₃^?, CH₃OH or H₂O. The bandgaps between the HOMO and LUMO were estimated by cyclic voltammetry (CV) and diffuse reflectance spectroscopy (DRS) to be 3.43, 3.12, and 3.74 eV, respectively. Theoretical calculations on each structure gave similar results to the experiments. Frontier molecular orbital analyses showed that the higher electron density on the apical ligand, the lower the bandgap.     

Isomorphous brucinium 4‐nitro­benzoate methanol solvate and brucinium 4‐nitro­benzoate dihydrate

In isomorphous crystals of brucinium 4‐nitro­benzoate methanol solvate, C₂₃H₂₇N₂O₄⁺·C₇H₄NO₄⁻·CH₃OH, and brucinium 4‐nitro­benzoate dihydrate, C₂₃H₂₇N₂O₄⁺·C₇H₄NO₄⁻·2H₂O, the brucinium cations form reverse corrugated layers, in which the amine N and amide O atoms of the brucinium cations are located in the grooves and at convex points of the layer surface, respectively. Similarly, as observed for the commonly occurring corrugated brucinium layers, the amide O atoms of the cations are involved in hydrogen bonds in which solvent mol­ecules are the donors.     

Clarithromycin hydro­chloride 3.5‐hydrate

The absolute configuration was determined for the title compound, C₃₈H₇₀NO₁₃⁺·Cl^?·3.5H₂O. The cation contains a 14‐membered macrocyclic lactone and two sugars, namely cladinose and desos­amine. The six‐membered rings of the sugars adopt chair conformations. The structure is stabilized by strong hydrogen bonds, with O?O distances in the range 2.486 (9)–2.830 (5) Å; other distances are N?O = 2.860 (5), N?Cl = 3.134 (4) and O?Cl = 3.303 (4) Å.     

Hydrogen bonding in two salts of 3‐methylthio‐4‐(propargylthio)quinoline

In 3‐methyl­thio‐4‐(propargyl­thio)­quinolinium chloride monohydrate, C₁₃H₁₂NS₂⁺·Cl^?·H₂O, and 3‐methyl­thio‐4‐(propargyl­thio)­quinolinium tri­chloro­acetate, C₁₃H₁₂­NS₂⁺·­C₂Cl₃O₂^?, the terminal alkyne group forms C[triple‐bond]C—H?O hydrogen bonds of favourable geometry. The conformation of the flexible propargyl­thio group is different in the two structures.     

Anti‐inflammatory drugs. IX.

In the solid‐state structure of the title compound, C₄H₁₂N⁺·C₁₄H₁₀Cl₂NO₂^?·H₂O, the asymmetric unit contains one cation, one anion and a water mol­ecule. A complex network of hydrogen bonds is present. A comparison is made with the structure of the an­hydro­us salt.     

Tetrakis(chloromethyl)phosphonium chloride monohydrate

Tetrakis­(chloro­methyl)­phospho­nium chloride monohydrate, C₄H₈Cl₄P⁺·Cl^?·H₂O or P(CH₂Cl)₄⁺·Cl^?·H₂O, is the first crystal structure determination of a tetrakis­(halogeno­methyl)­phospho­nium compound to date. The only comparable structures known so far are of phospho­nium ions containing just one halogeno­methyl group. The solvent water mol­ecule interacts with the Cl^? anion via hydrogen bonds, with O?Cl distances of 3.230 (2) and 3.309 (2) Å. The structure also contains several C—H?Cl^? and C—H?O contacts, though with longer D?A distances [D?A 3.286 (3)–3.662 (2) Å] or bent D—H?A angles. For these reasons, the C—H?Cl^? and C—H?O interactions should not be considered as strong hydrogen bonds.     

Sodium hydrogen nitrilo­tri­acetate dihydrate

In the title compound, Na⁺·C₆H₈NO₆^?·2H₂O, the sodium ion is coordinated in a distorted octahedral manner by two carboxyl­ate O atoms and two water O atoms. Each of these water mol­ecules bridges two adjacent Na ions, resulting in two four‐membered rings of the type Na–O–Na–O.     

l‐Methioninium chloride and l‐seleno­methioninium chloride at 103 K

The crystal structures of the title compounds, (S)‐1‐carboxy‐3‐(methyl­sulfanyl)­propanaminium chloride, C₅H₁₂NO₂S⁺·Cl⁻, and (S)‐1‐carboxy‐3‐(methyl­selanyl)­propanaminium chloride, C₅H₁₂NO₂Se⁺·Cl⁻, are isomorphous. The proton­ated l ‐methionine and l ‐seleno­methionine mol­ecules have almost identical conformations and create very similar contacts with the Cl⁻ anions in the crystal structures of both compounds. The amino acid cations and the Cl⁻ anions are linked viaN—H⋯Cl⁻ and O—H⋯Cl⁻ hydrogen bonds.     

Two‐ and three‐dimensional hydrogen‐bonded structures in the 1:1 proton‐transfer compounds of 4,5‐dichlorophthalic acid with the isomeric monoaminobenzoic acids

The crystal structures of the 1:1 proton‐transfer compounds of 4,5‐dichlorophthalic acid with the three isomeric monoaminobenzoic acids, namely the hydrate 2‐carboxyanilinium 2‐carboxy‐4,5‐dichlorobenzoate dihydrate, C₇H₈NO₂⁺·C₈H₃Cl₂O₄⁻·2H₂O, (I), and the anhydrous salts 3‐carboxyanilinium 2‐carboxy‐4,5‐dichlorobenzoate, C₇H₈NO₂⁺·C₈H₃Cl₂O₄⁻, (II), and 4‐carboxyanilinium 2‐carboxy‐4,5‐dichlorobenzoate, C₇H₈NO₂⁺·C₈H₃Cl₂O₄⁻, (III), have been determined at 130 K. Compound (I) has a two‐dimensional hydrogen‐bonded sheet structure, while (II) and (III) are three‐dimensional. All three compounds feature sheet substructures formed through anilinium N⁺—H...O_carboxyl and anion carboxylic acid O—H...O_carboxyl interactions and, in the case of (I), additionally linked through the donor and acceptor associations of the solvent water molecules. However, (II) and (III) have additional lateral extensions of these substructures though cyclic R²₂(8) associations involving the carboxylic acid groups of the cations. Also, (II) and (III) have cation–anion π–π aromatic ring interactions. This work provides further examples illustrating the regular formation of network substructures in the 1:1 proton‐transfer salts of 4,5‐dichlorophthalic acid with the bifunctional aromatic amines.     

Synthesis and Surface Properties of Novel Cationic Gemini Surfactants

A series of novel cationic gemini surfactants, p-[C _n H_2n+1N⁺(CH₃)₂CH₂CH(OH)CH₂O]₂C₆H₄·2Cl^? [A(n = 12), B(n = 14) and C(n = 16)], containing a spacer group with two flexible and hydrophilic groups (2-hydroxy-1,3-propylene) on both sides of a rigid and hydrophobic group (1,4-dioxyphenylene) has been synthesized by the reaction of hydroquinone diglycidyl ether with N,N-dimethylalkylamine and N,N-dimethylalkylamine hydrochloride. Their surface-active properties have been investigated by surface tension measurement. The critical micelle concentration (cmc) values of the synthesized cationic gemini surfactants are one order of magnitude lower than those of their corresponding monomeric surfactants (C _n H_2n + 1N⁺(CH₃)₃·Cl^?). Both the cmc and surface tension at the cmc (γ_cmc) of A are lower than those of p-[C₁₂H₂₅N⁺(CH₃)₂CH₂]₂C₆H₄·2Cl^? (D). The novel cationic gemini surfactants A and B also show good foaming properties.     

Impact of the anion and chalcogen on the crystal structure and properties of 4,6‐dimethyl‐2‐pyrimido(thio)nium halides

By the reaction of urea or thiourea, acetylacetone and hydrogen halide (HF, HBr or HI), we have obtained seven new 4,6‐dimethyl‐2‐pyrimido(thio)nium salts, which were characterized by single‐crystal X‐ray diffraction, namely, 4,6‐dimethyl‐2‐oxo‐2,3‐dihydropyrimidin‐1‐ium bifluoride, C₆H₉N₂O⁺·HF₂^? or (dmpH)F₂H, 4,6‐dimethyl‐2‐oxo‐2,3‐dihydropyrimidin‐1‐ium bromide, C₆H₉N₂O⁺·Br^? or (dmpH)Br, 4,6‐dimethyl‐2‐oxo‐2,3‐dihydropyrimidin‐1‐ium iodide, C₆H₉N₂O⁺·I^? or (dmpH)I, 4,6‐dimethyl‐2‐oxo‐2,3‐dihydropyrimidin‐1‐ium iodide–urea (1/1), C₆H₉N₂O⁺·I^?·CH₄N₂O or (dmpH)I·ur, 4,6‐dimethyl‐2‐sulfanylidene‐2,3‐dihydropyrimidin‐1‐ium bifluoride–thiourea (1/1), C₆H₉N₂S⁺·HF₂^?·CH₄N₂S or (dmptH)F₂H·tu, 4,6‐dimethyl‐2‐sulfanylidene‐2,3‐dihydropyrimidin‐1‐ium bromide, C₆H₉N₂S⁺·Br^? or (dmptH)Br, and 4,6‐dimethyl‐2‐sulfanylidene‐2,3‐dihydropyrimidin‐1‐ium iodide, C₆H₉N₂S⁺·I^? or (dmptH)I. Three HCl derivatives were described previously in the literature, namely, 4,6‐dimethyl‐2‐oxo‐2,3‐dihydropyrimidin‐1‐ium chloride, (dmpH)Cl, 4,6‐dimethyl‐2‐sulfanylidene‐2,3‐dihydropyrimidin‐1‐ium chloride monohydrate, (dmptH)Cl·H₂O, and 4,6‐dimethyl‐2‐sulfanylidene‐2,3‐dihydropyrimidin‐1‐ium chloride–thiourea (1/1), (dmptH)Cl·tu. Structural analysis shows that in 9 out of 10 of these compounds, the ions form one‐dimensional chains or ribbons stabilized by hydrogen bonds. Only in one compound are parallel planes present. In all the structures, there are charge‐assisted N⁺—H…X^? hydrogen bonds, as well as weaker C_Ar⁺—H…X^? and π⁺…X^? interactions. The structures can be divided into five types according to their hydrogen‐bond patterns. All the compounds undergo thermal decomposition at relatively high temperatures (150–300 °C) without melting. Four oxopyrimidinium salts containing a π⁺…X^?…π⁺ sandwich‐like structural motif exhibit luminescent properties.